6533b7d3fe1ef96bd1260bfd

RESEARCH PRODUCT

208: Impact of posaconazole (POS) vs fluconazole (FLU) on cyclosporine (CsA) and tacrolimus (TAC) dosing in hematopoietic stem cell transplant (HSCT) recipients with graft-vs-host disease (GVHD)

T. BrundageHernando PatinoAmelia LangstonJeffrey H. LiptonAndrew J. Ullmann

subject

TransplantationPosaconazolebusiness.industryHematopoietic stem cellHematologybiochemical phenomena metabolism and nutritionbacterial infections and mycosesTacrolimusmedicine.anatomical_structureImmunologyMedicineDosingbusinessHost diseaseFluconazolemedicine.drughttps://doi.org/10.1016/j.bbmt.2006.12.212